CareLit · DOI-Nachweis · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Updated results and exploratory analysis of ESR1 mutations (ESR1m) circulating tumor DNA (ctDNA) dynamics from SERENA-6, a phase 3 trial of camizestrant+CDK4/6 inhibitor (CDK4/6i) for emergent ESR1 mutations (ESR1m) during first-line (1L)…
DOI 10.1055/s-0046-1819777
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Janni, F C Bidard, E L Mayer, Y H Park, C X Ma, M Cristofanilli, G Bianchini, K Kalinsky, SK L Chia, A Brufsky, P A Fasching, Z Nowecki, J Pascual, E Gal-Yam, W-P Chung, S-A Im, A Zambelli, F Dalenc, M Oliveira, S Fox, C Morrow, C Huang Bartlett, N C Turner
ZeitschriftSenologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe02/2026
Jahrgang / SeitenJg. 23 · S. e18-e19
Kernaussage aus der Literatur
Abstract-Vorschau
Updated results and exploratory analysis of ESR1 mutations (ESR1m) circulating tumor DNA (ctDNA) dynamics from SERENA-6, a phase 3 trial of camizestrant+CDK4/6 inhibitor (CDK4/6i) for emergent ESR1 mutations (ESR1m) during first-line (1L) endocrine-based therapy and ahead of disease progression in patients with HR+/HER2- advanced breast cancer (aBC)
Zitieren
Zitierempfehlung
W Janni, F C Bidard, E L Mayer, Y H Park, C X Ma, M Cristofanilli, G Bianchini, K Kalinsky, SK L Chia, A Brufsky, P A Fasching, Z Nowecki, J Pascual, E Gal-Yam, W-P Chung, S-A Im, A Zambelli, F Dalenc, M Oliveira, S Fox, C Morrow, C Huang Bartlett, N C Turner (2026) Updated results and exploratory analysis of ESR1 mutations (ESR1m) circulating tumor DNA (ctDNA) dynamics from SERENA-6, a phase 3 trial of camizestrant+CDK4/6 inhibitor (CDK4/6i) for emergent ESR1 mutations (ESR1m) during first-line (1L) endocrine-based therapy and ahead of disease progression in…. Senologie - Zeitschrift für Mammadiagnostik und -therapie, 23 (02), e18-e19. https://doi.org/10.1055/s-0046-1819777
Mit CareLit weiterarbeiten